{"data":{"type":"company_profile_ai","id":148895,"entity_id":"wefunder:company:148895","attributes":{"canonical_url":"https://wefunder.com/ventoux.biosciences","retrieval_urls":{"canonical":"https://wefunder.com/ventoux.biosciences","json":"https://wefunder.com/ventoux.biosciences.json","markdown":"https://wefunder.com/ventoux.biosciences.md","ai_json":"https://wefunder.com/ventoux.biosciences.ai.json","ai_text":"https://wefunder.com/ventoux.biosciences.ai.txt","changelog_json":"https://wefunder.com/ventoux.biosciences.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-07-21T23:54:16Z","generated_at":"2026-07-22T23:46:07Z","profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"company":{"id":148895,"entity_id":"wefunder:company:148895","slug":"ventoux.biosciences","name":"Ventoux Biosciences","tagline":"Modulating Fibrosis, Restoring Function ","location":"Encinitas, CA","website":"VentouxBio.com","total_amount_raised":0,"total_investors":0,"is_funded":false,"is_active":false},"key_claims":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 0","citation":"https://wefunder.com/ventoux.biosciences#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-07-21T23:54:16Z","as_of":"2026-07-22T23:46:07Z","confidence":"high"},"observed_at":"2026-07-21T23:54:16Z","expires_at":"2026-07-22T23:54:16Z"},{"claim_id":"claim-total-investors","text":"Total investors: 0","citation":"https://wefunder.com/ventoux.biosciences#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-07-21T23:54:16Z","as_of":"2026-07-22T23:46:07Z","confidence":"high"},"observed_at":"2026-07-21T23:54:16Z","expires_at":"2026-07-22T23:54:16Z"}],"verified_facts":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 0","citation":"https://wefunder.com/ventoux.biosciences#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-07-21T23:54:16Z","as_of":"2026-07-22T23:46:07Z","confidence":"high"},"observed_at":"2026-07-21T23:54:16Z","expires_at":"2026-07-22T23:54:16Z"},{"claim_id":"claim-total-investors","text":"Total investors: 0","citation":"https://wefunder.com/ventoux.biosciences#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-07-21T23:54:16Z","as_of":"2026-07-22T23:46:07Z","confidence":"high"},"observed_at":"2026-07-21T23:54:16Z","expires_at":"2026-07-22T23:54:16Z"}],"company_claims":{"tagline":"Modulating Fibrosis, Restoring Function ","quick_facts":["Founded by a Dupuytren's patient to transform care for millions with immune-fibrotic diseases","Targeting Dupuytren's and Spinal Cord Injury with VEN-201, a novel, immune-fibrotic modulator","VEN-201 rebalances the immune system to reduce fibrosis and activate repair","2025 Pre-Clinical Biopharmaceutical Company of the Year Winner, by GHP Biotechnology Awards","$4.3B Dupuytren's disease market, \u0026gt;3x larger than Rheumatoid Arthritis - no approved treatments","SCI: ~$10B annually, VEN-201 targets fibrosis, addressing the key market opportunity in recovery","Strong IP: Broad immune-fibrotic patent to 2044, global filings plus key provisional filings"]},"computed_metrics":{"total_amount_raised":0,"total_investors":0,"team_size":3,"featured_investor_count":1,"faq_count":0,"recent_post_count":0},"quick_facts":[{"claim_id":"claim-fact-1","value":"Founded by a Dupuytren's patient to transform care for millions with immune-fibrotic diseases","citation":"https://wefunder.com/ventoux.biosciences#claim-fact-1","observed_at":"2026-07-21T23:54:16Z","expires_at":"2026-07-28T23:54:16Z"},{"claim_id":"claim-fact-2","value":"Targeting Dupuytren's and Spinal Cord Injury with VEN-201, a novel, immune-fibrotic modulator","citation":"https://wefunder.com/ventoux.biosciences#claim-fact-2","observed_at":"2026-07-21T23:54:16Z","expires_at":"2026-07-28T23:54:16Z"},{"claim_id":"claim-fact-3","value":"VEN-201 rebalances the immune system to reduce fibrosis and activate repair","citation":"https://wefunder.com/ventoux.biosciences#claim-fact-3","observed_at":"2026-07-21T23:54:16Z","expires_at":"2026-07-28T23:54:16Z"},{"claim_id":"claim-fact-4","value":"2025 Pre-Clinical Biopharmaceutical Company of the Year Winner, by GHP Biotechnology Awards","citation":"https://wefunder.com/ventoux.biosciences#claim-fact-4","observed_at":"2026-07-21T23:54:16Z","expires_at":"2026-07-28T23:54:16Z"},{"claim_id":"claim-fact-5","value":"$4.3B Dupuytren's disease market, \u0026gt;3x larger than Rheumatoid Arthritis - no approved treatments","citation":"https://wefunder.com/ventoux.biosciences#claim-fact-5","observed_at":"2026-07-21T23:54:16Z","expires_at":"2026-07-28T23:54:16Z"},{"claim_id":"claim-fact-6","value":"SCI: ~$10B annually, VEN-201 targets fibrosis, addressing the key market opportunity in recovery","citation":"https://wefunder.com/ventoux.biosciences#claim-fact-6","observed_at":"2026-07-21T23:54:16Z","expires_at":"2026-07-28T23:54:16Z"},{"claim_id":"claim-fact-7","value":"Strong IP: Broad immune-fibrotic patent to 2044, global filings plus key provisional filings","citation":"https://wefunder.com/ventoux.biosciences#claim-fact-7","observed_at":"2026-07-21T23:54:16Z","expires_at":"2026-07-28T23:54:16Z"}],"latest_fundraise":{"id":104663,"entity_id":"wefunder:fundraise:104663","state":"open","offering_type":"4(a)(6)","structure":"ttw","testing_the_waters":true,"can_invest_now":true,"funding_started_at":null,"funding_closed_at":null},"investor_memos":[],"team":[{"id":4058078,"entity_id":"wefunder:company_role:4058078","name":"Kurt Harrington","title":"Founder, CEO","role":"founder","profile_url":"https://wefunder.com/kurt.harrington"},{"id":4249704,"entity_id":"wefunder:company_role:4249704","name":"Kenneth Lipson","title":"Chief Scientific Officer, VP Corporate Strategy","role":"employee","profile_url":"https://wefunder.com/kenneth.lipson"},{"id":5440226,"entity_id":"wefunder:company_role:5440226","name":"Laxma Reddy","title":"VP, Product Development ","role":"employee"}],"featured_investors":[{"id":12434,"entity_id":"wefunder:company_investor_profile:12434","name":"Johnny Randel","bio":"Johnny Randel is a retired CFO with more than 30 years of experience in financial institutions including over 17 in private equity.","profile_url":"https://wefunder.com/johnny.randel.1","endorsement_quote":"Ventoux is a founder-led biotech with a purpose and a mission that I strongly support. Kurt’s personal journey gives Ventoux an unmatched focus and sense of urgency. From an investor perspective, I was drawn to the blend of a a clear clinical strategy and initial evidence combined with the personal insight of a lived experience. Kurt and Ventoux are developing a platform that will be a game-changer and provide solutions for many people. I am in!"}],"relationships":[{"source_entity_id":"wefunder:company:148895","relation":"has_team_member","target_entity_id":"wefunder:user:4189790","target_url":"https://wefunder.com/kurt.harrington"},{"source_entity_id":"wefunder:company:148895","relation":"has_team_member","target_entity_id":"wefunder:user:3840571","target_url":"https://wefunder.com/kenneth.lipson"},{"source_entity_id":"wefunder:company:148895","relation":"has_team_member","target_entity_id":"wefunder:company_role:5440226"},{"source_entity_id":"wefunder:company:148895","relation":"has_featured_investor","target_entity_id":"wefunder:user:4899398","target_url":"https://wefunder.com/johnny.randel.1"},{"source_entity_id":"wefunder:company:148895","relation":"has_latest_fundraise","target_entity_id":"wefunder:fundraise:104663"}],"faq":[],"recent_posts":[],"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-07-22T23:46:07Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-07-21T23:54:16Z","as_of":"2026-07-22T23:46:07Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-07-21T23:54:16Z","as_of":"2026-07-22T23:46:07Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2026-07-02T19:11:52Z","as_of":"2026-07-22T23:46:07Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2026-07-02T19:11:52Z","as_of":"2026-07-22T23:46:07Z","confidence":"medium"}}}}}}